1. Metabolic Enzyme/Protease Neuronal Signaling Autophagy
  2. FAAH Autophagy
  3. 874902-19-9

874902-19-9

LY2183240 Chemical Structure

874902-19-9

Chemical Structure

  • LY2183240
  • CAS No: 874902-19-9
    Formula: C17H17N5O
    Molecular Weight: 307.35
  • IUPAC Name: 5-([1,1'-biphenyl]-4-ylmethyl)-N,N-dimethyl-1H-tetrazole-1-carboxamide
  • InChIKey: GZNIYOXWFCDBBJ-UHFFFAOYSA-N
  • SMILES: O=C(N(C)C)N1N=NN=C1CC(C=C2)=CC=C2C3=CC=CC=C3

Biological Activity: LY2183240 is a highly potent blocker of anandamide uptake (IC50= 270 pM; Ki=540 nM). LY2183240 is a potent, covalent inhibitor of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) with an IC50 of 12.4 nM. LY2183240 inactivates FAAH by carbamylation of the enzyme's serine nucleophile. LY2183240 also inhibits several other brain serine hydrolases with IC50s of 5.3, 0.09, 8.2 nM for MAG lipase, bh6 and KIAA1363, respectively[1][2] [3].

Cat. No. Product Name Purity Description
HY-10865 LY2183240 98.01% LY2183240 is a highly potent blocker of anandamide uptake (IC50= 270 pM; Ki=540 nM). LY2183240 is a potent, covalent inhibitor of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) with an IC50 of 12.4 nM. LY2183240 inactivates FAAH by carbamylation of the enzyme's serine nucleophile. LY2183240 also inhibits several other brain serine hydrolases with IC50s of 5.3, 0.09, 8.2 nM for MAG lipase, bh6 and KIAA1363, respectively .

References

Keywords:

LY2183240